Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
    January 01, 2020 - outcomes including sleep apnea, degenerative joint disease, diabetes, cardiovascular disease, cancer, liver … • Cancer • Cardiovascular disease • Sub-fertility • Diabetes • Degenerative joint disease • Liver
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
    September 01, 2014 - “limited” Page 33, line 44: “which is the rate limiting step for cholesterol synthesis in the liver … The Zieve article reported similar AE incidence, but numerically greater liver enzyme elevations and … There were 2 cases of elevated liver enzymes with combination therapy vs 1 with statin monotherapy. … considered possibly related to study treatment (rash with monotherapy, and myalgia and elevated liver
  3. effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
    December 01, 2013 - Infection Hepatitis C virus (HCV) is a major public health concern, the primary cause of death from liver … disease, and the leading cause for liver transplantation in the U.S. … who are prior nonresponders to IFN-RBV with other comorbid conditions such as nonalcoholic fatty liver … do not achieve a sustained virologic response (SVR) or viral cure, leaving them at risk for future liver … Effective treatment could also reduce the long-term costs of complications such as cirrhosis and liver
  4. effectivehealthcare.ahrq.gov/health-topics/spleen-diseases
  5. effectivehealthcare.ahrq.gov/health-topics/hodgkin-disease
  6. effectivehealthcare.ahrq.gov/health-topics/organ-donation
  7. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
    January 01, 2012 - Horizon Scanning System AHRQ Priority Area 11 – Peptic Ulcer Disease and Dyspepsia such as liver … with SBS is 30%. 24 Long-term parenteral nutrition (PN) can lead to serious side effects such as liver
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
    January 30, 2012 - Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … Food and Drug Administration GWTG Get With The Guidelines HAS-BLED hypertension, abnormal renal/liver
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
    February 05, 2025 - breast neoplasms/ or Colonic Neoplasms/ or exp Endocrine Gland Neoplasms/ or Intestinal Neoplasms/ or liver … or liver or lung?
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
    July 09, 2024 - breast neoplasms/ or Colonic Neoplasms/ or exp Endocrine Gland Neoplasms/ or Intestinal Neoplasms/ or liver … or liver or lung?
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - contraindicated with methadone or buprenorphine; history of methadone/buprenorphine maintenance; pregnant; liver
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - The HAS-BLED (H=hypertension, A=abnormal renal/liver function, S=stroke, B=bleeding history or predisposition … glomerular filtration rate; ESRD = end-stage renal disease; HAS-BLED = hypertension, abnormal renal/liver … Evidence-based Practice Center ESRD end-stage renal disease HAS-BLED hypertension, abnormal renal/liver
  13. effectivehealthcare.ahrq.gov/health-topics/reye-syndrome
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - Drug Class Mechanism Example Drugs Biguanide Suppresses glucose production by the liver § Metformin … L iv er in ju ry The risk of liver injury was similar for thiazolidinediones and sulfonylureas. … The rates of liver injury were similar between thiazolidinediones and metformin. … (Insufficient) New Evidence: L iv er in ju ry The risk of liver injury was similar for thiazolidinediones … (High) New Evidence: The rates of liver injury were similar between thiazolidinediones and metformin
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - 2 supports the use of MTX as the oral DMARD of choice unless there are contraindications (e.g., liver
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - contraindicated with methadone or buprenorphine; history of methadone/buprenorphine maintenance; pregnant; liver
  17. effectivehealthcare.ahrq.gov/health-topics/viral-infections
  18. effectivehealthcare.ahrq.gov/health-topics/thalassemia
  19. effectivehealthcare.ahrq.gov/health-topics/alcohol
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
    May 01, 2023 - preeclampsia with and without severe features, eclampsia (seizure), and HELLP (hemolysis, elevated liver

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: